Onyx is now licensed to manufacture commercial API from our UK facility
Here at Onyx, our experts are committed to bringing you their latest insights from the API development and manufacturing industry. In our knowledge hub you can find an array of content curated to help you overcome challenges and achieve success.
Introduction The development of a synthetic route for clinical API […]
Read more
At Onyx Scientific, we deliver custom syntheses in support of […]
Read more
At Onyx, we perform non-GMP scale up campaigns for your […]
Read more
At Onyx Scientific, we deliver process research and development services […]
Read more
Onyx’s MHRA-licensed sites in the UK specialise in offering an […]
Read more
Our MHRA-licensed sites in the UK provide analytical services and […]
Read more
Onyx Scientific is a small molecule CDMO that offers commercial […]
Read more
Onyx Scientific is the CDMO division of Ipca Laboratories. Since […]
Read more
Introduction Solid form optimisation and screening is a critical part […]
Read more
Leading small molecule CDMO Onyx Scientific has its sights set […]
Read more
The Onyx Approach to HPLC Method Development High-Performance Liquid Chromatography […]
Read more
During the process of creating pharmaceuticals, one significant concern is […]
Read more
N-nitrosamines are organic compounds with the chemical structure R2N-N=O. N-nitrosodimethylamine […]
Read more
In a recent article, Drug Target Review spoke to Onyx’s […]
Read more
Leading small molecule CDMO Onyx Scientific is set to expand […]
Read more
As the demand for sustainably produced medicines rises, to ensure […]
Read more
The pharma industry significantly contributes to greenhouse gas emissions, primarily […]
Read more
Technological advancements such as in silico screening tools and artificial intelligence have […]
Read more
The pharma industry is currently striving to embrace sustainable practices […]
Read more
Salt screening is a systematic approach used to identify the […]
Read more
Developing novel pharmaceutical agents for clinical trials can be challenging for any pharmaceutical innovator. In particular, many drug candidates currently emerging from the discovery stage prese...
Read more
The landscape presented to those developing novel pharmaceutical agents for […]
Read more
Sunderland, UK, 28 March – Onyx Scientific, a leading CDMO […]
Read more
Onyx Scientific, a small molecule API contract development and manufacturing […]
Read more
The pharmaceutical industry is evolving and the outsourcing landscape is changing with it. For larger pharmaceutical companies there is a trend towards scaling back their internal capabilities and ...
Read more
The factors you should consider when identifying and selecting a partner for your next API manufacturing and development project.Selecting the right contract services provider is a vital step in th...
Read more
Most drug products are administered as solids, with the solid-form properties of active pharmaceutical ingredients (APIs) having a significant impact on a drug’s solubility, dissolution rate, stabi...
Read more
Ipca Laboratories Ltd. is pleased to announce the acquisition of 100% share capital of Pisgah Labs Inc., a North Carolina Corporation, Old Hendersonville Highway, Pisgah Forest, North Carolina, USA...
Read more
Onyx Scientific has announced that it has made a strategic investment to position the company for a commercial API license. Driven by growing demand for flexible, specialist and small-scale API man...
Read more